News & Events
-
October 15, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D’Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015 Oct 15;61Suppl 3:S102–18.
-
October 15, 2015
Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform
Starks AM, Avilés E, Cirillo DM, Denkinger CM, Dolinger DL, Emerson C, Gallarda J, Hanna D, Kim PS, Liwski R, Miotto P, Schito M, Zignol M. Collaborative Effort for a Centralized Worldwide Tuberculosis Relational Sequencing Data Platform. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015 Oct 15;61Suppl 3:S141–6.
-
October 15, 2015
Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines
Schito M, Migliori GB, Fletcher HA, McNerney R, Centis R, D’Ambrosio L, Bates M, Kibiki G, Kapata N, Corrah T, Bomanji J, Vilaplana C, Johnson D, Mwaba P, Maeurer M, Zumla A. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines. Clin Infectious Dis. 2015;61(suppl 3):S102–18.
-
October 15, 2015
Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done
Schito M, Maeurer M, Kim P, Hanna D, Zumla A. Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done. Clin Infectious Dis. 2015;61(suppl 3):S95–101.
-
October 1, 2015
A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers
Schito M, Dolinger DL. A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers. EBioMedicine. 2015 Oct;2(10):1262–5.